Amarin reported $45.66M in Trade Creditors for its fiscal quarter ending in March of 2025.


Trade Creditors Change Date
AbbVie 2.94B 2.66B Dec/2024
Alnylam Pharmaceuticals USD 102.39M 4.99M Jun/2025
Amarin USD 45.66M 5.3M Mar/2025
AstraZeneca 23.99B 1.44B Jun/2025
DBV Technologies USD 40.79M 6.65M Jun/2025
GlaxoSmithKline 14.82B 329M Jun/2025
Halozyme Therapeutics USD 18.69M 1.38M Jun/2025
Ionis Pharmaceuticals USD 22.8M 5.34M Jun/2025
Neurocrine Biosciences 104.6M 5.4M Jun/2025
Novartis USD 4.51B 245M Jun/2025